4.16 USD
↘ 0.16 (3.71%)AT CLOSE (03:59 PM EDT)
Briacell Therapeutics Corp. Common Shares
BCTXNASDAQ • USD
4.23
↗ 0.07 (1.78%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
4.23
↗ 0.07 (1.78%)
Market: CLOSED
Shares of Briacell Therapeutics Corp. Common Shares (BCTX) are trading at $4.00. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 28, 2026.
Open?$4.21
High?$4.40
Low?$4.01
Prev. Close?$4.32
Volume?294.2K
Avg. Volume?476.3K
VWAP?$4.24
Rel. Volume?0.62x
Bid / Ask
Bid?$4.05 × 500
Ask?$4.38 × 200
Spread?$0.33
Midpoint?$4.22
Valuation & Ratios
Market Cap?36.2M
Shares Out?8.7M
Float?7.1M
Float %?97.5%
P/E Ratio?N/A
P/B Ratio?1.50
EPS?-$3.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?29
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.96Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?11.21%High
Short Interest?792.2K
Days to Cover?8.6
Free Float7.1M
Avg Daily Volume92.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?7.07Strong
Quick Ratio?7.07Strong
Cash Ratio?1.92Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.50CHEAP▾
Peers100
S&P87
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-127.5%WEAK▾
S&P3
ROA?-113.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30951946
Enterprise Value?$29.3M
Fundamentals ratios updated end of day